283 related articles for article (PubMed ID: 35232446)
1. Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis.
Tong T; Gu J; Xu D; Song L; Zhao Q; Cheng F; Yuan Z; Tian S; Yang X; Tian J; Wang K; Jiang T
BMC Med; 2022 Mar; 20(1):74. PubMed ID: 35232446
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of pancreatic ductal adenocarcinoma diagnosis from endoscopic ultrasonography images with the assistance of deep learning.
Gu J; Pan J; Hu J; Dai L; Zhang K; Wang B; He M; Zhao Q; Jiang T
Cancer; 2023 Jul; 129(14):2214-2223. PubMed ID: 36999572
[TBL] [Abstract][Full Text] [Related]
3. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma.
Shi S; Lin C; Zhou J; Wei L; Chen M; Zhang J; Cao K; Fan Y; Huang B; Luo Y; Feng ST
Int J Surg; 2024 May; 110(5):2669-2678. PubMed ID: 38445459
[TBL] [Abstract][Full Text] [Related]
5. One 3D VOI-based deep learning radiomics strategy, clinical model and radiologists for predicting lymph node metastases in pancreatic ductal adenocarcinoma based on multiphasic contrast-enhanced computer tomography.
Liao H; Yang J; Li Y; Liang H; Ye J; Liu Y
Front Oncol; 2022; 12():990156. PubMed ID: 36158647
[TBL] [Abstract][Full Text] [Related]
6. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence using deep learning analysis of endoscopic ultrasonography images for the differential diagnosis of pancreatic masses.
Kuwahara T; Hara K; Mizuno N; Haba S; Okuno N; Kuraishi Y; Fumihara D; Yanaidani T; Ishikawa S; Yasuda T; Yamada M; Onishi S; Yamada K; Tanaka T; Tajika M; Niwa Y; Yamaguchi R; Shimizu Y
Endoscopy; 2023 Feb; 55(2):140-149. PubMed ID: 35688454
[TBL] [Abstract][Full Text] [Related]
8. Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma.
An C; Li D; Li S; Li W; Tong T; Liu L; Jiang D; Jiang L; Ruan G; Hai N; Fu Y; Wang K; Zhuo S; Tian J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1187-1199. PubMed ID: 34651229
[TBL] [Abstract][Full Text] [Related]
9. Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.
Deng Y; Ming B; Zhou T; Wu JL; Chen Y; Liu P; Zhang J; Zhang SY; Chen TW; Zhang XM
Front Oncol; 2021; 11():620981. PubMed ID: 33842325
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-based deep learning radiomics nomogram for risk stratification of testicular masses: a two-center study.
Fang F; Sun Y; Huang H; Huang Y; Luo X; Yao W; Wei L; Xie G; Wu Y; Lu Z; Zhao J; Li C
J Cancer Res Clin Oncol; 2024 Jan; 150(1):18. PubMed ID: 38240867
[TBL] [Abstract][Full Text] [Related]
13. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
[TBL] [Abstract][Full Text] [Related]
14. Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.
Bian Y; Zheng Z; Fang X; Jiang H; Zhu M; Yu J; Zhao H; Zhang L; Yao J; Lu L; Lu J; Shao C
Radiology; 2023 Jan; 306(1):160-169. PubMed ID: 36066369
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
16. Predicting the recurrence risk of pancreatic neuroendocrine neoplasms after radical resection using deep learning radiomics with preoperative computed tomography images.
Song C; Wang M; Luo Y; Chen J; Peng Z; Wang Y; Zhang H; Li ZP; Shen J; Huang B; Feng ST
Ann Transl Med; 2021 May; 9(10):833. PubMed ID: 34164467
[TBL] [Abstract][Full Text] [Related]
17. Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study.
Zhao B; Xia C; Xia T; Qiu Y; Zhu L; Cao B; Gao Y; Ge R; Cai W; Ding Z; Yu Q; Lu C; Tang T; Wang Y; Song Y; Long X; Ye J; Lu D; Ju S
Int J Surg; 2024 Feb; 110(2):740-749. PubMed ID: 38085810
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
19. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
[TBL] [Abstract][Full Text] [Related]
20. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
